Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BCL6 corepressor pseudogene 1 (BCORP1) is classified as a pseudogene related to the BCL6 corepressor gene (BCOR). Pseudogenes are DNA sequences resembling functional genes but are typically non-functional; they do not code for functional proteins and do not have the regulatory activities of their parental genes. There is no evidence supporting a direct functional role, target activity, or disease association for BCORP1. All available research and biomedical databases focus on BCOR (BCL6 corepressor) as a biologically important gene/protein, not BCORP1, and the latter should not be confused with the functional BCL6 corepressor or its protein products[2][3]. - BCORP1 is a pseudogene and not an active therapeutic target, enzyme, receptor, or other molecularly active biomolecule. - Its naming similarity to "BCOR," which is the true BCL6 corepressor, sometimes leads to confusion, but BCORP1 itself does not produce functional protein and is not involved in biological pathways or disease processes[2][3]. - No information exists on drug interactions, biological function, or disease roles for BCORP1; all such information pertains to BCOR and not its pseudogenes[2][3]. If information was sought on *BCL6 corepressor (BCOR)* instead of *BCL6 corepressor pseudogene 1 (BCORP1)*, the target would be a functionally significant transcriptional corepressor involved in development and disease, but that does not apply to BCORP1[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCL6 corepressor pseudogene 1 (BCORP1).